Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion.
about
Addiction science: Uncovering neurobiological complexityGenomic analysis to guide choice of treatment for smoking cessationAntidepressants for smoking cessationAntidepressants for smoking cessationNicotine chemistry, metabolism, kinetics and biomarkersComparative dynamics of four smoking withdrawal symptom scalesA review of pharmacogenetic studies of substance-related disordersPredictors of Variation in CYP2A6 mRNA, Protein, and Enzyme Activity in a Human Liver Bank: Influence of Genetic and Nongenetic Factors.The relationship between the nicotine metabolite ratio and three self-report measures of nicotine dependence across sex and race.Design, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological data.Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite RatioIntegrative variable selection via Bayesian model uncertaintyNicotine dependence as a moderator of genetic influences on smoking cessation treatment outcome.A novel CYP2A6 allele (CYP2A6*35) resulting in an amino-acid substitution (Asn438Tyr) is associated with lower CYP2A6 activity in vivo.Pharmacogenetics of nicotine addiction: role of dopamineKnown and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokersPharmacology of nicotine: addiction, smoking-induced disease, and therapeuticsGlucuronidation genotypes and nicotine metabolic phenotypes: importance of functional UGT2B10 and UGT2B17 polymorphismsPharmacological intervention of nicotine dependence.Pathways to precision medicine in smoking cessation treatments.Pharmacogenetic Optimization of Smoking Cessation Treatment.Associations of CYP2A6 genotype with smoking behaviors in southern China.Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level.Variation in trans-3'-hydroxycotinine glucuronidation does not alter the nicotine metabolite ratio or nicotine intake.Pharmacogenetics: a tool for identifying genetic factors in drug dependence and response to treatmentGender-stratified gene and gene-treatment interactions in smoking cessationToward personalized smoking-cessation treatment: Using a predictive modeling approach to guide decisions regarding stimulant medication treatment of attention-deficit/hyperactivity disorder (ADHD) in smokers.CYP2A6 Polymorphisms May Strengthen Individualized Treatment for Nicotine Dependence.Time dependency of craving and response inhibition during nicotine abstinence.Biomarkers of Response to Smoking Cessation Pharmacotherapies: Progress to Date.Biomarkers to optimize the treatment of nicotine dependence.Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial.A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism.The effects of extended pre-quit varenicline treatment on smoking behavior and short-term abstinence: a randomized clinical trialRapid nicotine clearance is associated with greater reward and heart rate increases from intravenous nicotineNicotine metabolite ratio (3-hydroxycotinine/cotinine) in plasma and urine by different analytical methods and laboratories: implications for clinical implementation.Smokescreen: a targeted genotyping array for addiction researchNicotine Dependence, Nicotine Metabolism, and the Extent of Compensation in Response to Reduced Nicotine Content Cigarettes.Rate of nicotine metabolism and smoking cessation outcomes in a community-based sample of treatment-seeking smokers.Test-Retest Reliability and Stability of the Nicotine Metabolite Ratio Among Treatment-Seeking Smokers
P2860
Q22251251-37F59E18-D314-412D-B064-AD549BF16BD3Q24188234-3088D059-50D7-4A28-AE24-95821502890EQ24201167-A11DDD8D-CC03-45EB-B3A1-C1F751B694CFQ24246426-7B6A7BEB-1DBC-4BDF-B433-8AA4E239A830Q24632647-11F95F01-5E0A-40BF-84AF-E0C4BB99AAB9Q26828556-9F86CCF6-B500-4995-9255-341780DC4971Q27312296-D9AF02ED-B1E5-4C83-937B-C9B1C50AD5C0Q33458739-0E009D7F-F406-41C9-8ACE-86A63F0BD240Q33693188-55078E59-184D-4CD1-AEC6-6951FFDB9A32Q33803436-8B0B83B2-CFBF-411F-ACD6-04B0574EE04FQ33821233-C75AA5E3-DD14-4BBF-A576-93640642E71DQ33858485-8CFCCC61-5550-4BE4-823E-74288E10A5C3Q33893086-CE3EF5E4-E1B5-4765-A08D-F95D2F93A400Q34068238-4FEF7AAE-BB44-417A-9355-595001DF378BQ34132214-76A3BEB2-9CC6-421E-8B2D-9311FE7357ACQ34135377-C7482DC6-B0E8-4068-8C58-212C7933D3AFQ34157674-F224B212-5C74-4433-8F56-FB87E11FAAC5Q34390412-201B7F00-67FB-4834-A4E5-00C86BC5FC2EQ34401794-A7009632-2D79-4815-9C57-A7619DD090BBQ34527740-79E9B6DC-E40B-4E75-A209-495701372448Q34542169-14422FD9-F8EB-4482-BD1F-5ED3A60ABC69Q34778875-EEAC5019-3C54-40CE-9503-2CD29EC8B2E5Q34799785-5D56C9E4-B5FA-48D7-BC77-DBA7841ED793Q34926339-7228208D-0B42-4E08-9EFD-1C5DCBBBEEAAQ35059965-8EC0BF00-C25F-46A9-997D-59BF22446AA3Q35523896-3319D538-0D9F-4AEE-9425-94F7627C9408Q35588731-C94A040C-67E4-4D28-877B-748882A5AF5AQ35594492-F54435CE-70F6-4287-9C03-5186207ECC88Q35684529-752B303D-128B-40D9-8084-3E730A85D7E1Q35751986-5C686F0F-712C-479A-901C-91AD39C1DF6FQ35773685-F56B634D-2DAC-4A34-AB96-C6B5BFC5C414Q35782141-979C5D94-61AC-4A35-AD2E-F830705382CEQ35788753-7D64142B-ADBD-48DA-B1E0-757B135601E2Q35885499-BA292B02-CCF1-4EA6-9D13-2F191DE23C30Q35892758-43406921-81CA-4DB3-8890-90AFA391BDB4Q35920608-5D130AF1-9CDD-4F46-9942-1B9D3ACE638CQ35938102-608B52C6-E896-48EB-8615-B42D17CE338DQ35974959-2A54631C-0196-4CC9-8722-8B468E8D45D1Q36021256-A5216B71-68C5-43F7-8F4B-E08BAF63ECCAQ36303865-80A209A5-8D26-4E7D-8353-64381D47D098
P2860
Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Toward personalized therapy fo ...... controlled trial of bupropion.
@en
Toward personalized therapy fo ...... controlled trial of bupropion.
@nl
type
label
Toward personalized therapy fo ...... controlled trial of bupropion.
@en
Toward personalized therapy fo ...... controlled trial of bupropion.
@nl
prefLabel
Toward personalized therapy fo ...... controlled trial of bupropion.
@en
Toward personalized therapy fo ...... controlled trial of bupropion.
@nl
P2093
P2860
P356
P1476
Toward personalized therapy fo ...... -controlled trial of bupropion
@en
P2093
E P Wileyto
F Patterson
L H Epstein
N Benowitz
P G Shields
R A Schnoll
P2860
P304
P356
10.1038/CLPT.2008.57
P407
P577
2008-04-02T00:00:00Z